ClinicalTrials.gg
RecruitingNCT07483151Updated Mar 19, 2026

Venous Congestion And Cognitive Dysfunction After Cardiac Surgery

An observational study in Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery, sponsored by Zhuan Zhang. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Zhuan Zhang · Observational

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative cognitive dysfunction (POCD) is a common central nervous system complication after surgery and anesthesia. Its primary clinical manifestations include a significant decline in cognitive abilities after surgery and anesthesia, encompassing memory, attention, coordination, orientation, language fluency, and executive function. POCD may persist for weeks or even years, affecting patient recovery, prolonging hospital stays, and potentially leading to additional physical and mental illnesses, increased mortality, and a significant burden on patients and their families. In cardiac surgery patients, the incidence of POCD ranges from 30% to 80% in the weeks following the procedure. The brain tissue is enclosed in a rigid anatomical structure; when there is an obstruction to venous return from the brain, intracranial pressure can increase, and blood supply to the brain tissue can decrease, leading to central nervous system dysfunction.

Systemic venous congestion can occur when there is right heart dysfunction or excessive volume load. When right heart failure and/or volume overload occurs, changes in right atrial pressure are transmitted to the venous system of organs throughout the body, with dilatation of the inferior vena cava (IVC), obstruction of blood return from the hepatic, portal, and renal veins, and abnormal venous flow signals and altered ultrasound Doppler flow patterns.

The primary objective of this prospective cohort study is to explore if intraoperative systemic venous congestion is associated with POCD after cardiac surgery. This study will also investigate the relationship between intraoperative systemic venous congestion and postoperative complications, and the relationship between each separate venous congestion and POD after cardiac surgery.

02

Conditions studied

  • Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery

Keywords

  • Venous Congestion
  • Cardiac Surgery
  • Postoperative cognitive dysfunction (POCD)
03

In context

Hyperemia

98 studies on the registry are indexed under Hyperemia; 44 are open to participants now.

This study's planned enrollment of 110 is close to the median of 100 across 46 observational studies indexed under Hyperemia.

Browse Hyperemia studies →

Lead sponsor

Zhuan Zhang is the lead sponsor of 16 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients scheduled to undergo elective cardiac surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients scheduled to undergo elective cardiac surgery via a midline thoracic incision;
  2. ≥18 years;
  3. A preoperative score>23, without consciousness or language barriers, capable of cooperating with neurological examinations, cognitive function tests, and other assessments of neurological function.

Exclusion criteria

Exclusion Criteria:

  1. for TEE;
  2. Emergency cardiac surgery;
  3. Major vascular surgery;
  4. Redo cardiac surgery;
  5. Severe infection requiring continuous antibiotic therapy;
  6. Severe preoperative heart failure with \< 30%;
  7. A critical preoperative state (mechanical circulatory support, extracorporeal membrane oxygenation, current renal replacement therapy, mechanical ventilation, or cardiac arrest necessitating resuscitation);
  8. Multi-organ dysfunction;
  9. Known conditions that may interfere with the assessment or interpretation of hepatic vein, portal vein blood flow (such as liver cirrhosis or portal vein thrombosis) or the renal vein blood flow (such as urinary tract obstruction);
  10. Planned cardiac transplantation or ventricular assist device implantation;
  11. Pregnancy;
  12. Insufficient ultrasonographic imaging;
  13. Restarting CPB after first CPB cessation during surgery;
  14. Requirement for cardiac assist devices (ECMO, IABP, or ventricular assist device) after CPB intraoperatively;
  15. Neurological or psychiatric diagnoses that may affect cognitive performance or cognitive testing;
  16. Documented delirium before surgery
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult patients scheduled to undergo elective cardiac surgery

    1. Patients scheduled to undergo elective cardiac surgery via a midline thoracic incision; 2. ≥18 years; 3. A preoperative MMSE score\>23, without consciousness or language barriers, capable of cooperating with neurological examinations, cognitive function tests, and other assessments of neurological function.

    Other: collection of demographic characteristics and comorbidities · Other: surgery-related parameters · Other: POCD assessments · Other: collection of biological (laboratory) parameters · Other: collection of hemodynamic parameters · Other: collection of echocardiographic parameters and venous ultrasound assessments · Other: collection of parameters monitoring on the central nervous system

Interventions

  • Othercollection of demographic characteristics and comorbidities

    1. gender, age, BMI, ASA classification, NYHA (New York Heart Association) classification, MMSE score. 2. smoking history, medical history (hypertension, diabetes mellitus, Hyperlipidemia, stroke, anaemia, chronic obstructive pulmonary disease, pulmonary hypertension, preoperative atrial fibrillation, peripheral artery disease), preoperative ACEI, ARB, beta-blockers, loop diuretics, aspirin, and spironolactone use.

  • Othersurgery-related parameters

    1. surgery type, surgery duration, CPB duration, aortic cross-clamp duration, blood loss, intraoperative fluid infusion, intraoperative urine output, intraoperative blood transfusion, intraoperative anesthetics and vasoactive medications. 2. duration of mechanical ventilation, duration of vasopressor support, postoperative acute kidney injury incidence and CRRT initiation, major bleeding, deep sternal wound infection/mediastinitis, surgical re-intervention, ICU LOS, hospital LOS, postoperative stroke, complications up to 30 days after surgery, 30-day inpatient mortality, survival status at discharge, and one year follow-up. 3. a composite endpoint of major complications after surgery defined as at least one of the following: death, prolonged ventilation (\>24 h), stroke, severe AKI, deep sternal wound infection, and reoperation for any reason.

  • OtherPOCD assessments

    Assessments of POCD at day 7, day 15, month 1, month 3, and month 6 postoperatively.

  • Othercollection of biological (laboratory) parameters

    1. WBC, CRP, IL-6, IL-10, IL-1β, TNF-α, serum Amyloid A, procalcitonin, catecholamines, cortisol, SOD, HIF-1α; 2. BDNF, S-100β protein, NSE; 3. CK-MB, NT pro-BNP, BNP, high-sensitivity troponin level; 4. hemoglobin, hematocrit, sodium, arterial lactate, and liver enzymes.

  • Othercollection of hemodynamic parameters

    1. blood pressure, heart rate, CVP; 2. CO, CI, SV, SVI,SVV; 3. intra-abdominal pressure; 4. vasoactive drug doses in the first hour in the ICU.

  • Othercollection of echocardiographic parameters and venous ultrasound assessments

    (1) Left ventricle systolic function, including LVOT, LVEF, MPI; left ventricular diastolic function, including mitral flow-derived Doppler indices, pulmonary vein Doppler indices. (2) Right ventricular systolic function, including TAPSE. Right ventricular diastolic dysfunction, inferred from an abnormal hepatic vein flow (systolic velocity \< diastolic velocity) in the absence of a dysrhythmia or pacing. (3) Inferior vena cava (IVC) measurements. (4) Hepatic vein Doppler parameters. (5) Portal vein Doppler parameters. (6) Renal vein Doppler parameters.

  • Othercollection of parameters monitoring on the central nervous system

    1. Regional cerebral oximetry. 2. Brain wave patterns. 3. Optic nerve sheath diameter.

06

What researchers measure

Primary outcomes

  1. Postoperative cognitive dysfunction after surgery

    Postoperative cognitive dysfunction (POCD) is assessed using Mini-Mental State Examination (MMSE).

    Time frame: day 7, day 15, month 1, month 3, and month 6 after surgery

07

Study locations

1 of 1 sites recruiting
  • The Department of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou University
    Yangzhou, Jiangsu 225012, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07483151
Lead sponsor
Zhuan Zhang
Responsible party
Zhuan Zhang (MD, the Deputy Director of Anesthesiology, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou University) — Sponsor-investigator
First posted
Mar 19, 2026
Start date
Nov 1, 2024
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Zhuan Zhang, MD
Contact
zhangzhuancg@163.com
+8615062791355

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion